CardiaTec
ID: 16332104CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.
2
Funding Rounds
$8.2m
Money raised
Recent Funding Rounds
Overview
CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.
- Website:
- Business model: B2B
- Headquarters: Cambridge, Cambridgeshire
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Na***** Ha* |
|
- | |
| Ra***** Pe***** |
|
- | |
| Th**** Za****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company CardiaTec has raised a total of $8.2m in funding over 2 rounds.
Key Insights:
- CardiaTec Seed Round, September 2024: $6.5m
- CardiaTec Biosciences July 2022 Pre-Seed Funding Round: $1.7m
Industries
CardiaTec is active in the following industries: